scholarly journals Clinical Effects of a 6-Month Treatment Course of Ibandronate, Vitamin D, and Calcium in Postmenopausal Women from Central America: Results of a Multinational, Prospective Pilot Study

2016 ◽  
Vol 3 (1-2) ◽  
pp. 82-88
Author(s):  
Carmen Elena Gutierrez ◽  
Helga Codina ◽  
Cesar Benjamin Matamoros Pinel ◽  
Edin Hidalgo ◽  
Arturo Arellano ◽  
...  
2009 ◽  
Vol 6 (11) ◽  
pp. 3132-3138 ◽  
Author(s):  
Cesare Battaglia ◽  
Arianna Cianciosi ◽  
Fulvia Mancini ◽  
Raffaella Fabbri ◽  
Paolo Busacchi ◽  
...  

2011 ◽  
Vol 37 (10) ◽  
pp. 1415-1422 ◽  
Author(s):  
Maria Creatsa ◽  
Paraskevi Pliatsika ◽  
George Kaparos ◽  
Aristidis Antoniou ◽  
Eleni Armeni ◽  
...  

2012 ◽  
Vol 18 (12) ◽  
pp. 1797-1800 ◽  
Author(s):  
Aideen C Allen ◽  
Siobhan Kelly ◽  
Sharee A Basdeo ◽  
Katie Kinsella ◽  
Keith J Mulready ◽  
...  

Although vitamin D deficiency is considered an environmental factor in multiple sclerosis (MS), the immunological and clinical effects of vitamin D supplementation remain unclear. We performed a pilot study of the immunomodulatory effects of vitamin D in healthy individuals ( n=4), who took 5000–10,000 IU/day of vitamin D over 15 weeks. After 15 weeks of vitamin D supplementation, serum 25(OH) vitamin D levels rose significantly from baseline, with a corresponding increase in IL-10 production by peripheral blood mononuclear cells and a reduced frequency of Th17 cells. These data provide a strong rationale for randomised trials to assess the clinical effects of vitamin D supplementation in MS.


JBMR Plus ◽  
2018 ◽  
Vol 2 (5) ◽  
pp. 281-288 ◽  
Author(s):  
Martin Blomberg Jensen ◽  
Henrik Husted ◽  
Poul Jannik Bjerrum ◽  
Anders Juul ◽  
Henrik Kehlet

Sign in / Sign up

Export Citation Format

Share Document